CCL2 and cancer: Similarly, CANTO888 antibodies were used for anti-CCL2 inhibition [236]; despite the fact that in vivo docetaxel cancer treatment was more effective than CANTO888 antibody treatment alone, the inhibition of CCL2 in combination with docetaxel significantly reduced the tumor load and induced tumor regression.